Editor’s note: Joan Siefert Rose is CEO of LaunchBio.
DURHAM – Due to public health concerns related to COVID-19, LaunchBio is going virtual. You can now join LaunchBio from anywhere in the world to experience our programming for biotech entrepreneurs.
We’ll host the first in our series of online Larger Than Life Science events on March 26. Register for ’Thinking Ahead’ today and we’ll send you the link to participate in the webinar. If you can’t make the live webcast, RSVP anyway. We’ll send you a link to the recording following the event.
When its been deemed safe to do so, we will return to our in-peson Larger Than Life Science events. In the meantime we’ll make sure you have uninterrupted access to the best minds in life science entrepreneurship. If you have questions or suggestions, please send them to email@example.com.
We’ll soon be posting details on our upcoming webinars and recorded programs. Check the website for details. We hope you’ll tune in — and share with your friends, too.
Webinar: Regenerative medicine
The global regenerative medicine market is expected to reach $5.6 billion by 2025. Due to its wide range of applications regenerative medicine will continue to gain traction both within research institutions and with investors looking to ride the wave. Join our panel of experts to explore the promise and possibilities.
- Matt Bresnahan, Partner, Wilson Sonsini
- Samuel Chuang, PhD, Director, Scientific Advisory Services at Charles River Laboratories
- Westbrook Weaver, PhD, Founder and Chief Executive Officer, Tempo Therapeutics Inc.
- Karen Christman, PhD, Professor, Bioengineering, UC San Diego